Why Classification Is Critical
In the UAE, a product’s regulatory path is heavily influenced by how it is classified. Misclassification can lead to delays, extra costs, and even enforcement actions if a product is placed on the market under the wrong regulatory regime. For companies entering the Gulf region, understanding the line between cosmetics, medicines, medical devices, and other product types is therefore essential.
The UAE authorities, including MoIAT and Dubai Municipality, make this distinction based largely on intended use and claims. The official definition of a cosmetic focuses on external application for purposes such as cleansing, perfuming, altering appearance, protecting, or maintaining body parts in good condition. Under this framework and the broader Cosmetics legislation, products that go beyond these functions or claim to treat diseases are likely to be regulated differently.
Examples of Non-Cosmetic Products
A number of personal care items that might look like cosmetics at first glance are, in fact, regulated as non-cosmetic products in the UAE. The key criterion is whether they are intended to prevent, diagnose, or treat a disease, or to significantly alter physiological functions through pharmacological or metabolic action.
Common examples include acne treatments that claim to cure or significantly reduce inflammatory lesions, creams for eczema or psoriasis, and products marketed for rosacea or severely weakened capillaries. Treatments for tired or heavy legs linked to varicose veins, as well as hair loss or alopecia remedies, also often fall under pharmaceutical or medical device regulations rather than cosmetic rules. These products generally require different approvals, clinical evidence, and post-market obligations.
Recognising these distinctions early saves companies time and resources. A formula that was originally developed as a cosmetic may need to be reformulated or repositioned if the marketing team wishes to make strong therapeutic claims.
Borderline Products and the Role of Claims
“Borderline” products are those that sit on the edge between cosmetics and other regulated categories. The same cream, for instance, could be considered a cosmetic if it is presented as a moisturiser, but a medicinal product if the labelling claims it cures atopic dermatitis. In such cases, the wording of product claims, the presence of certain active substances, and supporting data all influence how authorities interpret classification.
Under UAE Cosmetics legislation, regulators carefully examine not just the ingredient list but also promotional materials, websites, and social media posts. If the overall presentation suggests therapeutic intent, reclassification may occur. This is why many brands turn to specialist consultancies like CE.way for advice on claim substantiation and proper positioning. By aligning marketing messages with the cosmetic definition, companies reduce the risk of being forced into a more demanding regulatory pathway.
Practical Support for Brands Entering the UAE
Because classification decisions affect everything from testing requirements to labelling and documentation, professional guidance is invaluable. Advisors can review formulas, claims, and packaging texts to determine the most likely regulatory category. They can also suggest adjustments that keep products within the cosmetic scope while still appealing to consumers.
In practice, this might involve rephrasing claims from “treats” or “cures” to “helps reduce the appearance of”, or ensuring that active ingredients with strong pharmacological effects are avoided in cosmetic products. Such strategic choices allow companies to benefit from the cosmetic registration system while staying firmly within the boundaries set by UAE authorities. With the right support, brands can confidently build portfolios that comply with local rules and resonate with regional consumers.
